Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases
The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in a “dramatic” reduction in cases.
The German company BioNTech and the American pharmaceutical firm Pfizer announced to worldwide acclaim last week that their jointly developed vaccine candidate had proved 90% effective in stopping people from falling ill.
The UK government’s joint committee on vaccination and immunisation has published a list of groups of people who will be prioritised to receive a vaccine for Covid-19. The list is:
